These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28617940)

  • 1. Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol.
    Rosenberg EC; Louik J; Conway E; Devinsky O; Friedman D
    Epilepsia; 2017 Aug; 58(8):e96-e100. PubMed ID: 28617940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
    Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.
    Gaston TE; Szaflarski M; Hansen B; Bebin EM; Szaflarski JP;
    Epilepsy Behav; 2019 Jun; 95():10-17. PubMed ID: 31003195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly purified cannabidiol in the treatment of drug-resistant epilepsies: A real-life impact on seizure frequency, quality of life, behavior, and sleep patterns from a single Italian center.
    Ferrera G; Ricci E; Vignoli A; Savini MN; Viganò I; Chiesa V; Caputo D; Zambrelli E; La Briola F; Turner K; Canevini MP
    Epilepsy Behav; 2023 Oct; 147():109409. PubMed ID: 37677907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy.
    Thompson MD; Martin RC; Grayson LP; Ampah SB; Cutter G; Szaflarski JP; Bebin EM
    Epilepsy Behav; 2020 Oct; 111():107299. PubMed ID: 32759071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of epilepsy and antiepileptic drugs on health and quality of life in Indian children.
    Nagabushana D; S PK; Agadi JB
    Epilepsy Behav; 2019 Apr; 93():43-48. PubMed ID: 30831401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
    Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
    CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study.
    Szaflarski JP; Bebin EM; Cutter G; DeWolfe J; Dure LS; Gaston TE; Kankirawatana P; Liu Y; Singh R; Standaert DG; Thomas AE; Ver Hoef LW;
    Epilepsy Behav; 2018 Oct; 87():131-136. PubMed ID: 30100226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expectations and knowledge of cannabidiol therapy for childhood epilepsy - A German caregiver survey.
    Klotz KA; Schönberger J; Nakamura L; San Antonio-Arce V; Bast T; Wiemer-Kruel A; Schubert-Bast S; Borggraefe I; Syrbe S; Jacobs J
    Epilepsy Behav; 2020 Oct; 111():107268. PubMed ID: 32645621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?
    Uliel-Sibony S; Hausman-Kedem M; Fattal-Valevski A; Kramer U
    Brain Dev; 2021 Jan; 43(1):89-96. PubMed ID: 32713661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol.
    Anderson CL; Evans V; Gorham L; Liu Z; Johnson CR; Carney PR
    Epilepsy Behav; 2021 Sep; 124():108325. PubMed ID: 34560358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
    Savage TE; Sourbron J; Bruno PL; Skirvin LA; Wolper ES; Anagnos CJ; Thiele EA
    Epilepsy Res; 2020 Feb; 160():106263. PubMed ID: 31923763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of cannabidiol (CBD) in children with treatment-resistant epilepsy: Results from a state-based expanded access program.
    Park YD; Linder DF; Pope J; Flamini JR; Moretz K; Diamond MP; Long SA
    Epilepsy Behav; 2020 Nov; 112():107474. PubMed ID: 33181893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
    Hess EJ; Moody KA; Geffrey AL; Pollack SF; Skirvin LA; Bruno PL; Paolini JL; Thiele EA
    Epilepsia; 2016 Oct; 57(10):1617-1624. PubMed ID: 27696387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
    Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA
    Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes.
    Devinsky O; Verducci C; Thiele EA; Laux LC; Patel AD; Filloux F; Szaflarski JP; Wilfong A; Clark GD; Park YD; Seltzer LE; Bebin EM; Flamini R; Wechsler RT; Friedman D
    Epilepsy Behav; 2018 Sep; 86():131-137. PubMed ID: 30006259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial.
    O'Brien TJ; Berkovic SF; French JA; Messenheimer JA; Sebree TB; Bonn-Miller MO; Gutterman DL;
    JAMA Netw Open; 2022 Jul; 5(7):e2220189. PubMed ID: 35802375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy.
    Szaflarski M; Hansen B; Bebin EM; Szaflarski JP
    Epilepsy Behav; 2017 May; 70(Pt B):364-369. PubMed ID: 28236578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.